CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($)	3 Months Ended		9 Months Ended
	Dec. 31, 2019	Dec. 31, 2018	Dec. 31, 2019	Dec. 31, 2018
CONSOLIDATED STATEMENTS OF OPERATIONS
Net sales	$ 262,077	$ 419,326	$ 814,111	$ 1,199,814
Cost of sales	94,562	145,536	239,432	367,606
Gross profit	167,515	273,790	574,679	832,208
Operating Expenses
Research and development	0	0	0	120
Sales and marketing	94,867	200,981	295,165	536,353
General and administrative	178,919	270,204	507,914	713,025
Depreciation and amortization	16,745	24,982	58,314	74,317
TOTAL OPERATING EXPENSES	290,531	496,167	861,393	1,323,815
(LOSS) INCOME FROM OPERATIONS	(123,016)	(222,377)	(286,714)	(491,607)
OTHER INCOME (EXPENSES)
Equity (loss) income from investments	(30,799)	24,029	(201,751)	58,427
Interest expense	(2,029)	(2,656)	(5,039)	(5,390)
Interest /Other income	0	1,011	(1,355)	1,240
Other deductions	(5,755)	(1,803)	(1,788)	(3,860)
TOTAL OTHER INCOME	(38,583)	20,581	(209,933)	50,417
NET INCOME BEFORE NON-CONTROLLING INTEREST	(161,599)	(201,796)	(496,647)	(441,190)
PROVISION FOR INCOME TAXES	(1,683)	(874)	(1,683)	(874)
INCOME FROM CONTINUING OPERATIONS BEFORE NON-CONTROLLING INTEREST, NET OF TAX	(163,282)	(202,670)	(498,330)	(442,064)
NET INCOME (LOSS) ATTRIBUTABLE TO NON-CONTROLLING INTEREST	(14,756)	(14,917)	932	(19,395)
NET (LOSS) ATTRIBUTABLE TO REMEDENT INC. COMMON SHAREHOLDERS	$ (148,526)	$ (187,753)	$ (499,262)	$ (422,669)
INCOME PER SHARE
Basic	$ (0.01)	$ (0.01)	$ (0.02)	$ (0.02)
Fully diluted	$ (0.01)	$ (0.01)	$ (0.02)	$ (0.02)
WEIGHTED AVERAGE SHARES OUTSTANDING
Basic	19,995,969	19,995,969	19,995,969	19,995,969
Fully diluted	19,995,969	19,995,969	19,995,969	19,995,969